May 31, 2018

GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 07, 2021

    5 Patent Cases To Watch In The Second Half Of 2021

    The U.S. Supreme Court will be deciding later this year whether to take up a highly controversial patent eligibility case, while a California federal court mulls whether discretionary denial precedent at the Patent Trial and Appeal Board is legal. Here are five cases in patent attorneys' sights for the rest of the year.

6 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login